Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Featured Matter | November 01, 2022

Represented a large consumer electronics company against a well-known NPE that held a portfolio of mobile SEPs.

Featured Matter | November 01, 2022

Defended a large consumer electronics company in the Southern District of California against infringement claims relating to patents asserted to be MPEG standard essential

Featured Matter | November 01, 2022

Defended a large consumer electronics company in the District of Massachusetts against assertions of infringement against the company 's multi-billion dollar mobile products business.

Featured Matter | November 01, 2022

Series of Hatch-Waxman cases regarding a leading pharmaceutical company 's glaucoma drug.

Featured Matter | November 01, 2022

Trial counsel for leading pharmaceutical company in five-day bench trial in July 2013 in Hatch-Waxman case

Featured Matter | November 01, 2022

Trial counsel for leading pharmaceutical company in eight-day bench trial in November 2012 in Hatch-Waxman case

Featured Matter | November 01, 2022

Trial counsel for leading pharmaceutical company in bench trial in October 2016 in Hatch-Waxman case

Featured Matter | November 01, 2022

Trial counsel for leading pharmaceutical company in bench trial in August 2011 in Hatch-Waxman case

Featured Matter | November 01, 2022

Successfully prosecuted reissue of patent for pharma client

Featured Matter | November 01, 2022

Prosecuted patents covering clinical leads

Featured Matter | November 01, 2022

Serves as co-lead counsel for a new Hatch-Waxman global litigation for Gilead Sciences

Featured Matter | November 01, 2022

Secured an early settlement on behalf of electronic payment processor in patent infringement case